Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4477-4484, Vol. 67, No. 9
Department of Microbiology and Immunology,
Temple University School of Medicine, Philadelphia, Pennsylvania
19140,1 and the Department of
Microbiology and Immunology, Finch University of the Health
Sciences, Chicago Medical School, North Chicago, Illinois
600642
Received 13 November 1998/Returned for modification 5 January
1999/Accepted 16 June 1999
The most abundant protein on the surface of the promastigote form
of the protozoan parasites Leishmania spp. is a 63-kDa
molecule, designated gp63 or leishmanolysin. Because gp63 has been
shown to possess fibronectin-like properties, we examined the
interaction of gp63 with the cellular receptors for fibronectin. We
measured the direct binding of Leishmania to human
macrophages or to transfected mammalian cells expressing human
fibronectin receptors. Leishmania expressing gp63 exhibited
modest but reproducible adhesion to human macrophages and to
transfected CHO cells expressing gp63 is the major surface protein on
Leishmania promastigotes (3). Due to its
abundance and its characterization as a zinc-metalloproteinase (9), much work has been done to define a role for gp63 in
Leishmania virulence (4, 7). Previous studies
have implicated gp63 as a ligand for multiple macrophage receptors,
including Mac-1 (CD11b/CD18) (26, 33) and the cellular
receptors for fibronectin (22). The gp63 molecule is highly
conserved among all species of Leishmania (16);
this conservation includes the amino acid sequence SRYD, which is found
at amino acids 252 to 255 in Leishmania major
(5). Soteriadou et al. (29) demonstrated that the
SRYD region of gp63 was antigenically similar to the RGDS region of fibronectin. Antibodies against fibronectin have been shown to cross-react with gp63 (22, 29) and to inhibit the binding of
promastigotes to macrophages (22, 37). Wyler et al.
(37) demonstrated that RGDS-containing peptides could
inhibit the immunoprecipitation of gp63 by antibodies to fibronectin.
Two of the most abundant cellular receptors for fibronectin are members
of the It has previously been demonstrated that the presence of gp63 on the
surface of promastigotes can enhance their interaction with murine
macrophages (6, 13, 14). Here we examine the importance of
gp63 and specifically the SRYD region of gp63 in the interaction of
promastigotes with human macrophages. We demonstrate that gp63 on
Leishmania can bind specifically to human Macrophages.
Mononuclear cells were isolated from human
peripheral blood with Lymphoprep (Nycomed Pharma, Oslo, Norway) as
specified by the manufacturer. To obtain monocyte-derived macrophages,
monocytes were cultured for 4 to 5 days in Teflon beakers (Savilex,
Minnetonka, Minn.) containing RPMI 1640 supplemented with glutamine,
penicillin-streptomycin (Mediatech, Herndon, Va.), and 5% autologous
serum. Cells were removed from beakers with cold cation-free
Dulbecco's phosphate-buffered saline (PBS) (GIBCO, Grand Island, N.Y.)
and washed in RPMI 1640. Cells were then allowed to adhere to
13-mm-diameter round glass coverslips overnight in the presence of 5%
autologous serum. Nonadherent cells were removed on the following day
by washing, and monolayers were used that day for
Leishmania-binding assays.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Interaction of Leishmania gp63 with
Cellular Receptors for Fibronectin

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
4/
1 fibronectin receptors. In
both cases, this interaction depended on gp63 but occurred
independently of the SRYD sequence of gp63, because parasites
expressing gp63 with a mutated SRYD sequence bound to macrophages and
4/
1 receptor-expressing cells as well as did wild-type parasites.
The contribution of gp63 to parasite adhesion was more pronounced when
the assays were performed in the presence of complement, suggesting
that the receptors for complement and fibronectin may cooperate to
mediate the efficient adhesion of parasites to macrophages. The
interaction of gp63 with fibronectin receptors may also play an
important role in parasite internalization by macrophages. Erythrocytes
to which gp63 was cross-linked were efficiently phagocytized by
macrophages, whereas control erythrocytes opsonized with complement
alone bound to macrophages but remained peripherally attached to the
outside of the cell. Similarly, parasites expressing wild-type gp63
were rapidly and efficiently phagocytized by resting macrophages,
whereas parasites lacking gp63 were internalized more slowly. This
rapid internalization of gp63-expressing parasites was dependent on the
1 integrins, because pretreatment of macrophages with monoclonal antibodies to the
1 integrins decreased the internalization of gp63-expressing parasites. These observations indicate that complement receptors are the primary mediators of parasite adhesion; however, maximal parasite adhesion and internalization may require the participation of the
1 integrins, which recognize fibronectin-like molecules such as gp63 on the surface of the parasite.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
1 integrin family, VLA-4 (CD49d/CD29) and VLA-5 (CD49e/CD29)
(24, 34). VLA-5, like many of the cellular receptors for
fibronectin, recognizes the Arg-Gly-Asp-Ser (RGDS) sequence of
fibronectin (20). VLA-4, in contrast, recognizes the CS-1
domain of fibronectin, which contains the amino acid sequence
Glu-Ile-Leu-Asp-Val (EILDV) (12). VLA-4 and VLA-5 are both
expressed on a wide range of tissues and cell types (32, 34), with VLA-4 appearing primarily on hematopoietic cells and being prominently expressed on macrophages and activated lymphocytes (34). The cooperation between fibronectin and complement
receptors has been suggested by several groups, who have observed that
the presence of fibronectin can enhance the phagocytosis of
complement-opsonized particles (2, 21, 27). These
observations have been extended to microbial phagocytosis. The FimD
molecule on Bordetella pertussis can enhance the
complement-dependent phagocytosis of that organism by interacting with
fibronectin receptors (11). Similarly, the interaction of
Mycobacterium avium with
3 integrins on macrophages enhances complement receptor expression and augments phagocytosis (10).
4/
1
fibronectin receptors. This is the first identification of a specific
fibronectin receptor with which Leishmania can interact. We
also demonstrate that the SRYD region of gp63, a domain previously
implicated in cell adhesion (26, 29), is not required for
this interaction. Finally, although gp63 can bind directly to
4/
1
receptors, the direct binding of parasites to human macrophages is
minimal unless complement is also present. In the presence of
complement, however, the interaction of gp63 with fibronectin receptors
may cooperate with complement receptor-dependent adhesion to mediate
the efficient attachment to and entry of parasites into macrophages.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Transfected CHO cells.
Clonal CHO cell lines stably
expressing wild-type human Mac-1 (8) and complement receptor
type 1 (CR1) (23) have been described previously. Mutant CHO
cells deficient in hamster
1 integrin expression (CHO-B2) or
transfected with constructs encoding either the human
4
(CHO-B2/
4) or the human
5 (CHO-B2/
5) subunit were kindly
provided by Rudolph Juliano, University of North Carolina (1,
28). Cells were maintained in alpha minimal essential medium
containing 10% HI FCS, 2 mM L-glutamine, 100 U of
penicillin G per ml, and 100 µg of streptomycin per ml. G418 was
added to transfected cell cultures at a final concentration of 200 µg/ml. To confirm integrin expression, transfected cells were stained with monoclonal antibodies (MAb) to
4/
1 (HP2/1) or
5/
1
(SAM1) receptors. These antibodies were generously provided to us by Stefan Niewiarowski, Temple University School of Medicine. Flow cytometry confirmed
1 integrin expression and demonstrated that the
4 subunit-transfected cells expressed
4/
1 but not
5/
1 on
their surface and that the
5 subunit-transfected cells expressed
5/
1 but not
4/
1 on their surface (Fig.
1).
|
Parasites. The C1250 variant of Leishmania amazonensis (LV78), expressing markedly reduced levels of gp63, and the transfection of C1250 with the gene encoding wild-type gp63 from L. major and with the gp63 gene containing a point mutation resulting in conversion of the SRYD sequence to SRDD have been previously described (14, 15). Briefly, plasmids encoding wild-type gp63 and mutant gp63 were prepared by use of Escherichia coli and isolated by cesium chloride-ethidium bromide density gradient centrifugation. They were transfected into the gp63-deficient variant of L. amazonensis by electroporation at 400 V with a capacitance of 450 µF. After a 5- to 8-h recovery in drug-free medium, transfectants were selected with G418 at 20 µg/ml. Transfectants which emerged in 1 to 2 weeks were further selected with 200 µg of G418 per ml. Stationary-phase organisms were used for all experiments unless otherwise stated.
gp63-coated erythrocytes. Recombinant gp63 was generously provided by Robert McMaster, University of British Columbia, Vancouver, British Columbia, Canada. Erythrocytes coated with Leishmania gp63 were generated as follows. 2-Iminothiolane (Pierce, Rockford, Ill.) was used to introduce sulfhydryl residues into gp63 according to the manufacturer's instructions. Briefly, gp63 (0.5 mg/ml) was incubated with 0.3 mM 2-iminothiolane in PBS containing 1 mM EDTA (pH 8.0) for 45 min at room temperature. Unreacted 2-iminothiolane was separated on a PD-10 column (Pharmacia, Piscataway, N.J.). gp63 containing sulfhydryl groups was coupled to sheep erythrocytes (SRBC) by a modification of a method described previously (31). Sulfosuccinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate (Pierce) at a final concentration of 0.5 mM was incubated with SRBC (109 cells/ml) in Hanks' balanced salt solution (HBSS) for 60 min at room temperature with continuous rotation. The thiol-activated SRBC were washed four times with HBSS, resuspended in gp63 containing sulfhydryl groups (0.4 mg/ml) to a concentration of 5 × 108 cells/ml, and incubated at room temperature with continuous rotation for 60 min. The resulting gp63-coated erythrocytes were washed three times with HBSS and resuspended to a concentration of 108 cells/ml.
Parasite-binding assays. For radiolabeling, promastigotes were cultivated in the presence of [3H]uracil (18). Radiolabeled parasites were washed and resuspended in phagocytosis buffer, which consists of equal parts of DMEM and medium 199 buffered with 25 mM HEPES (Mediatech) and supplemented with 1% bovine serum albumin. Parasites were added to 24-well plates containing either monocyte-derived macrophages on 13-mm-diameter round coverslips or transfected CHO cells plated directly on the plastic wells the night before. This overnight incubation allowed transfected cells to adhere tightly to the plastic, but this amount of time did not allow for significant cellular proliferation in the wells. For assays performed in the presence of serum, a final concentration of 4% serum from a patient with a deficiency in the eighth component of complement, C8D serum (19), was added to each well. Following 45 min of incubation at 35°C, the wells were washed thoroughly to remove unbound organisms. Monolayers and bound parasites were solubilized in 0.5% Triton X-100, and the amount of radioactivity associated with the cell lysates was determined with a Beckman LS6500 liquid scintillation counter. The absolute number of parasites in each well was determined by comparing the amount of radioactivity in the lysate to that of a standard curve of known numbers of radiolabeled parasites as previously described (18). All assays were performed in triplicate.
For Leishmania phagocytosis assays, unlabeled promastigotes were added to monolayers of murine bone marrow-derived macrophages in the presence of 4% C8D as a source of complement. After 10 min, monolayers were washed and immediately fixed in methanol. Parasites were stained by immunofluorescence with a murine polyclonal antiserum to L. amazonensis followed by fluorescein isothiocyanate (FITC)-conjugated antibody to mouse immunoglobulin G (Jackson ImmunoResearch, West Grove, Pa.). In contrast to peripherally attached promastigotes, internalized organisms were oval and were enclosed within phagocytic vacuoles.Binding of 125I-C3 to promastigotes. Purified human C3 was generously provided by John Lambris, University of Pennsylvania, Philadelphia. It was radiolabeled to a specific activity of 1.6 × 106 cpm/µg with IODO-BEADS (Pierce) as previously described (17). Leishmania promastigotes were resuspended to a concentration of 108 cells/ml in dextrose-Veronal buffer with 0.2% gelatin (dVBG). One hundred microliters of this suspension was mixed with 15 µl of C8D and 5 µl of 125I-C3, bringing the final concentration of radiolabeled C3 in the reaction mixture to 2.5 µg/ml. Samples were incubated for 15 min at 37°C and pelleted in a microcentrifuge for 3 min at room temperature. Following two washes with dVBG, parasites were resuspended in 100 µl of dVBG and washed with HBSS containing 1% bovine serum albumin. Following centrifugation, the supernatant was discarded, the contents in the bottom of the microcentrifuge tube, containing the pellet, were removed, and the amount of radiolabel associated with the cell pellet was determined on a Tracor Analytic Gamma Trac 1191 gamma counter. Nonspecific binding, the amount of radiolabel bound in the presence of serum which had been heat inactivated (30 min, 56°C) and treated with EDTA (10 mM), was subtracted from each value. The percentage of total radioactivity in the reaction mixture that remained associated with the cell pellet was multiplied by the total number of C3 molecules in the reaction mixture, assuming the C3 concentration in C8D to be 1.1 mg/ml (17). This product was then divided by the total number of cells in the reaction mixture to determine the number of C3 molecules bound per cell.
Erythrocyte binding and phagocytosis. Murine bone marrow-derived macrophages were allowed to adhere to 13-mm-diameter glass coverslips and were washed twice with phagocytosis buffer. Erythrocytes were opsonized with 10% C8D serum and added to the cells at a ratio of 50:1. Macrophages were incubated with the opsonized erythrocytes for 1 h at 37°C. Wells were washed with phagocytosis buffer in order to remove unbound erythrocytes. In order to differentiate surface-bound from internalized erythrocytes, parallel macrophage monolayers were subjected to hypotonic erythrocyte lysis with H2O for 15 s to lyse surface-bound erythrocytes. Monolayers were then fixed with 2.5% glutaraldehyde and stained with Giemsa stain (Accura Labs, Bridgeport, N.J.). The number of erythrocytes per macrophage was quantitated by light microscopy by examining 200 macrophages per coverslip.
Analysis of data.
Statistical analysis of all data was
performed with Student's t test, with statistical
significance defined as a P value of
0.05.
| |
RESULTS |
|---|
|
|
|---|
Direct binding of Leishmania to human monocyte-derived macrophages. We examined the interaction of Leishmania promastigotes with human monocyte-derived macrophages, with a particular interest in determining the relative contribution of gp63 to parasite adhesion. Three variants of Leishmania differing in gp63 expression were used for these studies. The gp63-deficient variant of L. amazonensis, designated C1250, and transfectants of C1250 expressing either wild-type L. major gp63 or gp63 containing a Y-254-D point mutation (SRY/D) have been previously described (14, 15). These organisms were added to human monocyte-derived macrophages in the presence (Fig. 2) or absence of fresh serum as a source of complement. In the absence of exogenous complement, there was only a modest degree of direct binding of parasites to human macrophages. Despite this modest degree of direct binding, parasites expressing gp63 on their surface bound significantly better to macrophages than did those lacking gp63 (Fig. 2, inset). This direct binding of parasites to macrophages was not dependent on the SRYD sequence of gp63, because an L. amazonensis variant expressing gp63 with the SRY/D mutation on the surface bound directly to macrophages as well as did parasites expressing wild-type gp63. Thus, parasites expressing gp63 on their surface exhibit a modest degree of direct binding to human macrophages.
|
Binding of Leishmania to transfected cells expressing
human fibronectin receptors.
Several groups have demonstrated that
gp63 has fibronectin-like properties (22, 29). Consequently,
we examined the interaction of Leishmania promastigotes with
cellular receptors for fibronectin. Leishmania parasites
were added to parallel monolayers of transfected CHO cells varying only
in their expression of recombinant human fibronectin receptors.
Exogenous opsonins, such as antibody or complement, were omitted from
the assay to examine the direct adhesion of parasites to these cells.
Parasites lacking gp63 (C1250) bound poorly to all three of
the cell types examined (Fig. 3). Parasites expressing wild-type gp63 (pXgp63), however, exhibited a
significant degree of binding to transfected cells expressing the
4
fibronectin receptor (VLA-4). This binding was specific, because these
parasites failed to bind to transfected cells expressing the
5/
1
fibronectin receptor (VLA-5). Because of the antigenic cross-reactivity
of the SRYD region of gp63 with the RGDS region of fibronectin
(29), we also examined parasites expressing recombinant gp63
lacking the intact SRYD sequence of gp63. Like parasites expressing
wild-type gp63, a variant of L. amazonensis (SRY/D) expressing gp63 containing a point mutation converting SRYD to SRDD on
the surface bound to cells expressing the
4/
1 receptor but not to
cells lacking fibronectin receptors or to those expressing the
5/
1 receptor (Fig. 3). Thus, parasites expressing gp63 exhibit modest direct adhesion to cellular receptors for fibronectin. The
specific fibronectin receptor which mediates this interaction is the
4/
1 fibronectin receptor. Neither the SRYD region of gp63 nor the
5/
1 receptor, which recognize the RGDS region of fibronectin, is
involved in this interaction.
|
Complement-dependent binding of Leishmania to human monocyte-derived macrophages. Parasite adhesion to macrophages in the presence of complement was studied in order to determine the significance of fibronectin-dependent binding relative to that mediated by complement. In the presence of complement, parasites bound efficiently to macrophages, as previously described (18). Fresh serum improved the binding of all three of the variants (Fig. 2) relative to their binding in the absence of serum. Surprisingly, however, complement opsonization did not improve binding for parasites lacking gp63 as well as it did for parasites expressing gp63. The two variants expressing gp63 bound significantly better to macrophages than did the gp63-deficient variant C1250 (Fig. 2). Thus, although parasites expressing gp63 on their surface exhibited only a modest increase in their direct binding to macrophages relative to the binding of the gp63-deficient variant, the presence of complement in the assay accentuated this difference and resulted in improved binding of gp63-expressing parasites to macrophages.
To examine the mechanism by which gp63 increased complement-dependent adhesion, the fixation of radiolabeled C3 to the three variants was measured. In the presence of complement, all three of the organisms fixed comparable amounts of radiolabeled C3, indicating that the reduced binding of the C1250 variant was not due to a failure to fix complement. In a single experiment that was performed in triplicate and that is representative of four experiments, the mean ± standard deviation values were (2.2 ± 0.19) × 10
5, (1.5 ± 0.20) × 10
5, and
(1.5 ± 0.09) × 10
5 molecules of
125I-C3 bound by C1250, pXgp63, and SRY/D,
respectively. To confirm that the C3 fixed to the parasites was
opsonic, the three variants of L. amazonensis were added to
transfected cells expressing human complement receptors in the presence
or absence of complement (Fig. 4). All
three of the organisms exhibited substantial amounts of
complement-dependent binding to transfected cells expressing either of
the two human complement receptors, CR1 or Mac-1 (Fig. 4). The degree
of complement-dependent adhesion of parasites to complement receptors
on transfected CHO cells was far in excess of the degree of direct
adhesion of parasites to
1 receptor-transfected cells (note
differences in the ordinates in Fig. 3 and 4). These data demonstrate
that all three of the variants studied can fix comparable amounts of
opsonic complement and bind to transfected cells expressing human
complement receptors. These results suggest that the efficient
complement-dependent binding of parasites expressing gp63 to human
macrophages (Fig. 2) is not due to differences in complement fixation
but rather is due to cooperation between fibronectin and complement
receptors.
|
Role of gp63 in promoting complement-dependent phagocytosis by macrophages. To determine whether fibronectin receptor ligation could improve not only adhesion but also phagocytosis, we used complement-opsonized sheep erythrocytes to which gp63 had been cross-linked (SRBC-gp63). As expected, normal sheep erythrocytes opsonized with complement bound to macrophages but remained peripherally attached rather than being phagocytized (Fig. 5). This observation confirms the work of several groups who have shown that on resident macrophages, complement receptors mediate particle adhesion but not internalization (36). Parallel monolayers of macrophages were exposed to SRBC-gp63. SRBC-gp63 were internalized far more efficiently than were erythrocytes opsonized with complement alone. The total number of SRBC-gp63 found inside macrophages (Fig. 5A) and the number of macrophages with three or more internalized erythrocytes (Fig. 5B) were dramatically increased relative to the data for erythrocytes opsonized with complement alone.
|
1 integrins was available to
us. Parasites expressing wild-type gp63 were added to monolayers of
macrophages in the presence or absence of the MAb to the
1 integrins. In the absence of the antibody, Leishmania
parasites were efficiently taken up by macrophages; by as little as 10 min, the majority of the parasites were located inside macrophages (Fig. 6), with very few remaining
peripherally attached. The presence of the blocking antibody to the
1 integrins inhibited parasite internalization and increased the
number of parasites that were peripherally attached to the macrophages.
Parasites lacking gp63 (C1250) exhibited an intermediate
rate of internalization. About half of the parasites were located
inside macrophages, and a substantial percentage of parasites remained
peripherally attached (Fig. 6). These data indicate that parasites
expressing gp63 are internalized more efficiently than those lacking
gp63 and that blocking the
1 integrins with an MAb can inhibit
parasite phagocytosis.
|
| |
DISCUSSION |
|---|
|
|
|---|
In the initial portion of these experiments, we examined the role
of Leishmania gp63 in mediating parasite adhesion to
mammalian cells. In vitro parasite adhesion assays were performed with
both monocyte-derived macrophages and CHO cells transfected with
fibronectin receptors. In both cases, when parasites were added to
these cells in the absence of opsonic complement, there was a modest
but significant adhesion of gp63-expressing parasites to these cells
relative to the adhesion of parasites lacking gp63. Although the amount of adhesion was only modest, there were several degrees of specificity to this interaction. First, adhesion was specific for the
4/
1 fibronectin receptor, since cells expressing a different fibronectin receptor,
5/
1, failed to show parasite adhesion. Second, the adhesion of parasites to these cells required gp63, since a variant of
L. amazonensis that expressed minimal amounts of endogenous gp63 failed to bind to
4/
1 receptor-expressing cells. Finally, the SRYD region of gp63 was not required for this interaction, since
parasites expressing a mutated form of gp63 bound to cells as well as
did those expressing wild-type gp63. This work confirms previous
studies by others which have shown that gp63 may be involved in the
adhesion of parasites to macrophages (22, 25, 29) and
extends these studies in several ways.
First, we identify one of the fibronectin receptors capable of gp63
recognition. This is the
4/
1 fibronectin receptor. Second, we
also demonstrate that the SRYD region of gp63 is not necessary for
parasite adhesion to the
4/
1 receptor. Previous studies have
suggested that the SRYD sequence of gp63 may mediate the adhesion of
parasites to fibronectin receptors. This assumption was based on the
observations that the SRYD region of gp63 is antigenically similar to
the RGD sequence of fibronectin (29) and that fibroblasts
plated on gp63 exhibit enhanced spreading, similar to their spreading
on fibronectin or RGD substrates (22, 37). The results of
these previous studies are consistent with the adhesion of fibroblasts
to gp63 being dependent on the SRYD sequence. Our experiments do not
refute this point. In fact, we also observed a low level of parasite
adhesion to fibroblasts which depended on an intact SRYD domain of gp63
(data not shown), confirming the fibronectin-like character of this
sequence. Rather than precluding a role for the SRYD region of gp63 in
binding to fibronectin receptors, our present observations indicate
that this region is not essential for the adhesion of parasites to macrophages. The lack of reliance on the SRYD region of gp63 for recognition by
4 integrins is consistent with previous reports that
the
4/
1 integrin recognizes an EILDV sequence (12)
rather than an RGD sequence. Although L. major gp63 contains
no EILDV amino acid sequence, it does contain an EYLEV sequence (amino acids 318 to 322) (5), which may mimic the
4/
1
recognition domain. The putative role of this potential
4/
1
recognition domain in gp63 must be further investigated in light of
previous work in which the LDV region of fibronectin was changed to
LEV, with a consequent reduction in the binding of fibronectin to the
4/
1 receptor (12).
The relatively small amounts of direct binding of parasites to fibronectin receptors might initially suggest that this interaction has only marginal biological significance. Subsequent data, however, indicate that this interaction may play a significant role in parasite adhesion. We show that the binding of gp63 to the Fn receptors may cooperate with complement-dependent adhesion to augment the complement-dependent adhesion of parasites to macrophages. Parasites deficient in gp63 exhibited markedly less complement-dependent adhesion to macrophages than did parasites expressing gp63 (Fig. 2). The fact that all three strains fixed comparable amounts of complement and bound reasonably well to recombinant human complement receptors (Fig. 4) suggests that this augmentation was due to cooperation between fibronectin and complement receptors on macrophages rather than to differences in complement fixation.
The ability of gp63 to bind to fibronectin receptors not only may
contribute to parasite adhesion but also may play an important role in
promoting parasite internalization by macrophages. Previous studies
have shown that complement-opsonized Leishmania
promastigotes are rapidly and efficiently internalized by resting
macrophages (18). Complement-opsonized erythrocytes, in
contrast, form rosettes around resting macrophages but are generally
not efficiently internalized (36). Internalization of
complement-opsonized particles may depend on the ligation of a second
class of receptors to cooperate with complement receptors. In other
model systems, the receptors for fibronectin have been implicated in
this cooperative role (21, 35). In the present work, we show
that both Leishmania organisms and erythrocytes coated with
gp63 are efficiently internalized by resting macrophages. This
internalization is blocked by an MAb to the
1 integrins, suggesting
that fibronectin receptors may participate in parasite internalization.
The delayed phagocytosis of the gp63-deficient variant
C1250 is consistent with gp63 being a ligand for these
receptors. The fact that this variant does eventually enter macrophages
suggests that gp63 may not be the only fibronectin-like molecule on
Leishmania.
Our previous experiments demonstrated that gp63 could participate in the interaction of promastigotes with macrophages by influencing complement fixation (4). The present experiments indicate a second way in which gp63 may facilitate the infection of macrophages by promastigotes. By interacting with cellular receptors for fibronectin, gp63 stabilizes the complement-dependent adhesion of parasites to macrophages and allows their rapid and efficient internalization.
| |
ACKNOWLEDGMENTS |
|---|
We thank Robert McMaster for the generous gift of gp63.
This work was supported by Public Health Service grants AI24313 (to D.M.M.) and AI20486 (to K.-P.C.) from the National Institutes of Health.
Andrew Brittingham and Gang Chen contributed equally to this work.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Temple University School of Medicine, 3400 N. Broad St., Philadelphia, PA 19140. Phone: (215) 707-8262. Fax: (215) 707-7788. E-mail: dmmosser{at}astro.temple.edu.
Present address: Department of Internal Medicine, University of
Iowa College of Medicine, Iowa City, IA 52242.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bauer, J. S.,
C. L. Schreiner,
F. G. Giancotti,
E. Ruoslahti, and R. L. Juliano.
1992.
Motility of fibronectin receptor deficient cells on fibronectin and vitronectin: collaborative interactions among integrins.
J. Cell Biol.
116:477-487 |
| 2. | Bohnsack, J. F., J. J. O'Shea, T. Takahashi, and E. J. Brown. 1985. Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1). J. Immunol. 135:2680-2686[Abstract]. |
| 3. |
Bouvier, J.,
R. J. Etges, and C. Bordier.
1985.
Identification and purification of membrane and soluble forms of the major surface protein of leishmania promastigotes.
J. Biol. Chem.
260:15504-15509 |
| 4. | Brittingham, A., C. J. Morrison, W. R. McMaster, B. S. McGwire, K. P. Chang, and D. M. Mosser. 1995. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol. 155:3102-3111[Abstract]. |
| 5. |
Button, L. L., and W. R. McMaster.
1988.
Molecular cloning of the major surface antigen of leishmania.
J. Exp. Med.
167:724-729 |
| 6. | Chakrabarty, R., S. Mukherjee, H.-G. Lu, B. S. McGwire, K. P. Chang, and M. K. Basu. 1996. Kinetics of entry of virulent and avirulent strains of Leishmania donovani into macrophages: a possible role of virulence molecules (gp63 and LPG). J. Parasitol. 82:632-635[Medline]. |
| 7. | Chang, K. P., and G. Chaudhuri. 1990. Molecular determinants of Leishmania virulence. Annu. Rev. Microbiol. 44:499-529[Medline]. |
| 8. |
Diamond, M. S.,
J. Garcia-Aquilar,
J. K. Bickford,
A. L. Corbi, and T. A. Springer.
1993.
The I domain is a major recognition site on leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands.
J. Cell Biol.
120:1031-1043 |
| 9. |
Etges, R.,
J. Bouvier, and C. Bordier.
1986.
The major surface protein of Leishmania promastigotes is a protease.
J. Biol. Chem.
261:9098-9101 |
| 10. |
Hayashi, T.,
S. P. Rao, and A. Catanzaro.
1997.
Binding of the 68-kilodalton protein of Mycobacterium avium to alpha(v)beta3 on human monocyte-derived macrophages enhances complement receptor type 3 expression.
Infect. Immun.
65:1211-1216 |
| 11. | Hazenbos, W. L., B. M. van den Berg, and R. van Furth. 1993. Very late antigen-5 and complement receptor type 3 cooperatively mediate the interaction between Bordetella pertussis and human macrophages. J. Immunol. 151:6274-6282[Abstract]. |
| 12. |
Komoriya, A.,
L. J. Green,
M. Miljenko,
K. M. Yamada, and M. J. Humphries.
1991.
The minimal essential sequence for a major cell type-specific adhesion site (CS-1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine.
J. Biol. Chem.
266:15075-15079 |
| 13. |
Liu, X., and K. P. Chang.
1992.
Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages.
Proc. Natl. Acad. Sci. USA
89:4991-4995 |
| 14. | McGwire, B. S., and K. P. Chang. 1994. Genetic rescue of surface metalloproteinase (gp63) deficiency in Leishmania amazonensis variants increases their infection of macrophages at the early phase. Mol. Biochem. Parasitol. 66:345-347[Medline]. |
| 15. |
McGwire, B. S., and K. P. Chang.
1996.
Posttranslational regulation of a Leishmania HEXXH metalloprotease (gp63).
J. Biol. Chem.
271:7903-7909 |
| 16. | Medina-Acosta, E., S. M. Beverley, and D. G. Russell. 1993. Evolution and expression of the Leishmania surface proteinase (gp63) gene locus. Infect. Agents Dis. 2:25-34[Medline]. |
| 17. | Mosser, D. M., S. K. Burke, E. E. Coutavas, J. F. Wedgwood, and P. J. Edelson. 1986. Leishmania species: mechanisms of complement activation by five strains of promastigotes. Exp. Parasitol. 62:394-404[Medline]. |
| 18. | Mosser, D. M., and P. J. Edelson. 1985. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of leishmania promastigotes. J. Immunol. 135:2785-2789[Abstract]. |
| 19. |
Mosser, D. M.,
T. A. Springer, and M. S. Diamond.
1992.
Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18).
J. Cell Biol.
116:511-520 |
| 20. | Pierschbacher, M. D., and E. Ruoslahti. 1984. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30-33[Medline]. |
| 21. |
Pommier, C. G.,
S. Inada,
L. F. Fries,
T. Takahashi,
M. M. Frang, and E. J. Brown.
1983.
Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes.
J. Exp. Med.
157:1844-1854 |
| 22. | Rizvi, F. S., M. A. Ouaissi, B. Marty, F. Santoro, and A. Capron. 1988. The major surface protein of Leishmania promastigotes is a fibronectin-like molecule. Eur. J. Immunol. 18:473-476[Medline]. |
| 23. |
Rosenthal, L. A.,
F. S. Sutterwala,
M. E. Kehrli, and D. M. Mosser.
1996.
Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion.
Infect. Immun.
64:2206-2215 |
| 24. | Ruoslahti, E. 1991. Integrins. J. Clin. Investig. 87:1-5. |
| 25. | Russell, D. G., and H. Wilhelm. 1986. The involvement of the major surface glycoprotein (gp63) of leishmania promastigotes in attachment to macrophages. J. Immunol. 136:2613-2620[Abstract]. |
| 26. |
Russell, D. G., and S. D. Wright.
1988.
Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp-containing region on the major surface glycoprotein, gp63, of leishmania promastigotes.
J. Exp. Med.
168:279-292 |
| 27. | Savoia, D., S. Biglino, A. Cestaro, and M. Zucca. 1992. Effect of fibronectin and interferon-gamma on the uptake of Leishmania major and Leishmania infantum promastigotes by U937 cells. Microbiologica 15:51-56[Medline]. |
| 28. |
Schreiner, C. L.,
J. S. Bauer,
Y. N. Danilov,
S. Hussein,
M. M. Sczkan, and R. L. Juliano.
1989.
Isolation and characterization of CHO cell variants deficient in the expression of fibronectin receptor.
J. Cell Biol.
109:3157-3167 |
| 29. |
Soteriadou, K. P.,
M. S. Remoundos,
M. C. Katsikas,
A. K. Tzinia,
V. Tsikaris,
C. Sakarellos, and S. J. Tzartos.
1992.
The Ser-Arg-Tyr-Asp region of the major surface glycoprotein of Leishmania mimics the Arg-Gly-Asp-Ser cell attachment region of fibronectin.
J. Biol. Chem.
267:13980-13985 |
| 30. |
Sutterwala, F. S.,
G. J. Noel,
P. S. Salgame, and D. M. Mosser.
1998.
Reversal of proinflammatory responses by ligating the macrophage Fc RI.
J. Exp. Med.
188:1-6 |
| 31. | Sutterwala, F. S., L. A. Rosenthal, and D. M. Mosser. 1996. Cooperation between CR1 (CD35) and CR3 (CD11b/CD18) in the binding of complement-opsonized particles. J. Leukocyte Biol. 59:883-890[Abstract]. |
| 32. |
Takada, Y.,
J. L. Strominger, and M. E. Hemler.
1987.
The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis.
Proc. Natl. Acad. Sci. USA
84:3239-3243 |
| 33. |
Van Strijp, J. A. G.,
D. G. Russell,
E. Toumanen,
E. J. Brown, and S. D. Wright.
1993.
Ligand specificity of purified complement receptor type three (CD11b/CD18, m 2, Mac-1).
J. Immunol.
151:3324-3336[Abstract].
|
| 34. |
Wayner, E. A.,
A. Garcia-Pardo,
M. J. Humphries,
J. A. McDonald, and W. G. Carter.
1989.
Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.
J. Cell Biol.
109:1321-1330 |
| 35. |
Wright, S. D.,
L. S. Craigmyle, and S. C. Silverstein.
1983.
Fibronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes.
J. Exp. Med.
158:1338-1343 |
| 36. |
Wright, S. D., and S. C. Silverstein.
1982.
Tumor-promoting phorbol esters stimulate C3b and C3b' receptor-mediated phagocytosis in cultured human monocytes.
J. Exp. Med.
156:1149-1164 |
| 37. |
Wyler, D. J.,
J. P. Sypek, and J. A. McDonald.
1985.
In vitro parasite-monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite attachment.
Infect. Immun.
49:305-311 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»